Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
ELASTATHERAPY
Second Extension - Granted
Show more
Pharmaceutical preparations and compositions for the treatment of acquired and congenital skin conditions and acquired and congenital skin diseases; biochemical and biological substances for medical use, namely, forms of protein and polysaccharide preparations for the treatment of acquired and congenital skin conditions and acquired and congenital skin diseases; drug delivery preparations for medical use, namely, forms of protein and polysaccharide preparations used for the controlled release of pharmaceuticals; medical preparations, namely, medicated skin care preparations
Class 5 – Pharmaceuticals & supplements
Status timeline
- 5 Feb 2024Application filedNew Application Entered
- 29 Aug 2024Assigned to an examining attorneyAssigned To Examiner
- 29 Aug 2024Office action issuedNon-Final Action Written
- 11 Nov 2024Response to office action filedTeas Response To Office Action Received
- 12 Nov 2024Approved for publicationApproved For Pub - Principal Register
- 10 Dec 2024Published for oppositionPublished For Opposition
- 4 Feb 2025Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 4 Aug 2025Statement-of-use extension 1 grantedSou Extension 1 Granted
- 4 Feb 2026Statement-of-use extension 2 grantedSou Extension 2 Granted
All 26 events
| 2026-07-14 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2026-07-14 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2026-07-14 | Teas Change Of Correspondence Received |
| 2026-07-14 | Teas Withdrawal Of Attorney Received-Firm Retains |
| 2026-05-14 | Notice Of Approval Of Extension Request E-Mailed |
| 2026-02-04 | Sou Teas Extension Received |
| 2026-02-04 | Sou Extension 2 Filed |
| 2026-02-04 | Sou Extension 2 Granted |
| 2025-08-05 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-08-04 | Sou Teas Extension Received |
| 2025-08-04 | Sou Extension 1 Filed |
| 2025-08-04 | Sou Extension 1 Granted |
| 2025-02-04 | Noa Mailed - Sou Required From Applicant |
| 2024-12-10 | Published For Opposition |
| 2024-12-10 | Official Gazette Publication Confirmation E-Mailed |
| 2024-12-04 | Notification Of Notice Of Publication E-Mailed |
| 2024-11-12 | Approved For Pub - Principal Register |
| 2024-11-11 | Teas Response To Office Action Received |
| 2024-11-11 | Correspondence Received In Law Office |
| 2024-11-11 | Teas/Email Correspondence Entered |
| 2024-08-29 | Assigned To Examiner |
| 2024-08-29 | Non-Final Action Written |
| 2024-08-29 | Non-Final Action E-Mailed |
| 2024-08-29 | Notification Of Non-Final Action E-Mailed |
| 2024-06-03 | New Application Office Supplied Data Entered |
| 2024-02-05 | New Application Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Pharmaceutical preparations and compositions for the treatment of acquired and congenital skin conditions and acquired and congenital skin diseases; biochemical and biological substances for medical use, namely, forms of protein and polysaccharide preparations for the treatment of acquired and congenital skin conditions and acquired and congenital skin diseases; drug delivery preparations for medical use, namely, forms of protein and polysaccharide preparations used for the controlled release of pharmaceuticals; medical preparations, namely, medicated skin care preparations
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 14 Jul 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.